Resources Repository
-
EditorialPublication 2020Waiting for Certainty on COVID-19 Antibody Tests — At What Cost?
This perspective anticipates the availability of serologic antibody testing and considers its potential usefulness in mitigation …
This perspective anticipates the availability of serologic antibody testing and considers its potential usefulness in mitigation policy to reduce COVID-19 transmission. For example: Could we screen for serologic antibodies as a proxy for possible immunity and identify people who could return to the workplace with less severe mitigation measures? The authors acknowledge the uncertainties raised by many policy actors, including the WHO, such as, "Do antibodies confer immunity and, if so, for how long? How accurate is…
Test Performance | Health/Medicine | Global | Health Systems | Probability/Bayes | Technology Assessment | Infectious Diseases | Policy/Regulation | Government/Law | North America -
DataWeb Portal 2024EuroQol
The EuroQol Group first met in 1987 in order to develop a standardized non-disease specific …
The EuroQol Group first met in 1987 in order to develop a standardized non-disease specific instrument to describe and value health-related quality of life. A process based on shared development, local experimentation and discussion resulted in EQ-5D, a measure that generates a single index value for health status for use in health care evaluation. EQ-5D is a standardized instrument developed as a measure of health-related quality of life that can be used in a wide…
Health/Medicine | Global | Health Systems | Preferences/Values